Literature DB >> 23716668

Deficits in human trisomy 21 iPSCs and neurons.

Jason P Weick1, Dustie L Held, George F Bonadurer, Matthew E Doers, Yan Liu, Chelsie Maguire, Aaron Clark, Joshua A Knackert, Katharine Molinarolo, Michael Musser, Lin Yao, Yingnan Yin, Jianfeng Lu, Xiaoqing Zhang, Su-Chun Zhang, Anita Bhattacharyya.   

Abstract

Down syndrome (trisomy 21) is the most common genetic cause of intellectual disability, but the precise molecular mechanisms underlying impaired cognition remain unclear. Elucidation of these mechanisms has been hindered by the lack of a model system that contains full trisomy of chromosome 21 (Ts21) in a human genome that enables normal gene regulation. To overcome this limitation, we created Ts21-induced pluripotent stem cells (iPSCs) from two sets of Ts21 human fibroblasts. One of the fibroblast lines had low level mosaicism for Ts21 and yielded Ts21 iPSCs and an isogenic control that is disomic for human chromosome 21 (HSA21). Differentiation of all Ts21 iPSCs yielded similar numbers of neurons expressing markers characteristic of dorsal forebrain neurons that were functionally similar to controls. Expression profiling of Ts21 iPSCs and their neuronal derivatives revealed changes in HSA21 genes consistent with the presence of 50% more genetic material as well as changes in non-HSA21 genes that suggested compensatory responses to oxidative stress. Ts21 neurons displayed reduced synaptic activity, affecting excitatory and inhibitory synapses equally. Thus, Ts21 iPSCs and neurons display unique developmental defects that are consistent with cognitive deficits in individuals with Down syndrome and may enable discovery of the underlying causes of and treatments for this disorder.

Entities:  

Keywords:  cerebral cortex; developmental disorders

Mesh:

Year:  2013        PMID: 23716668      PMCID: PMC3683748          DOI: 10.1073/pnas.1216575110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  59 in total

Review 1.  Too much of a good thing: mechanisms of gene action in Down syndrome.

Authors:  R H Reeves; L L Baxter; J T Richtsmeier
Journal:  Trends Genet       Date:  2001-02       Impact factor: 11.639

Review 2.  Chromosome 21: from sequence to applications.

Authors:  S E Antonarakis
Journal:  Curr Opin Genet Dev       Date:  2001-06       Impact factor: 5.578

3.  Human embryonic stem cells as models for aneuploid chromosomal syndromes.

Authors:  Juan-Carlos Biancotti; Kavita Narwani; Nicole Buehler; Berhan Mandefro; Tamar Golan-Lev; Ofra Yanuka; Amander Clark; David Hill; Nissim Benvenisty; Neta Lavon
Journal:  Stem Cells       Date:  2010-09       Impact factor: 6.277

4.  H(2)O(2) is a novel, endogenous modulator of synaptic dopamine release.

Authors:  B T Chen; M V Avshalumov; M E Rice
Journal:  J Neurophysiol       Date:  2001-06       Impact factor: 2.714

5.  Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome.

Authors:  Jorge Busciglio; Alejandra Pelsman; Caine Wong; Gustavo Pigino; Menglan Yuan; Hiroshi Mori; Bruce A Yankner
Journal:  Neuron       Date:  2002-02-28       Impact factor: 17.173

6.  Brain growth in Down syndrome subjects 15 to 22 weeks of gestational age and birth to 60 months.

Authors:  B Schmidt-Sidor; K E Wisniewski; T H Shepard; E A Sersen
Journal:  Clin Neuropathol       Date:  1990 Jul-Aug       Impact factor: 1.368

7.  ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons.

Authors:  Pablo Helguera; Alejandra Pelsman; Gustavo Pigino; Ernst Wolvetang; Elizabeth Head; Jorge Busciglio
Journal:  J Neurosci       Date:  2005-03-02       Impact factor: 6.167

8.  Abnormal neuronal development in the visual cortex of the human fetus and infant with down's syndrome. A quantitative and qualitative Golgi study.

Authors:  S Takashima; L E Becker; D L Armstrong; F Chan
Journal:  Brain Res       Date:  1981-11-23       Impact factor: 3.252

9.  Oxidative Stress and Mitochondrial Dysfunction in Down's Syndrome: Relevance to Aging and Dementia.

Authors:  Pinar E Coskun; Jorge Busciglio
Journal:  Curr Gerontol Geriatr Res       Date:  2012-04-29

Review 10.  The sequence of human chromosome 21 and implications for research into Down syndrome.

Authors:  K Gardiner; M Davisson
Journal:  Genome Biol       Date:  2000-08-04       Impact factor: 13.583

View more
  83 in total

1.  OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome.

Authors:  Ranjie Xu; Andrew T Brawner; Shenglan Li; Jing-Jing Liu; Hyosung Kim; Haipeng Xue; Zhiping P Pang; Woo-Yang Kim; Ronald P Hart; Ying Liu; Peng Jiang
Journal:  Cell Stem Cell       Date:  2019-05-23       Impact factor: 24.633

2.  The telomerase inhibitor AZT enhances differentiation and prevents overgrowth of human pluripotent stem cell-derived neural progenitors.

Authors:  Yao Hu; Kai-Heng Fang; Lu-Ping Shen; Shi-Ying Cao; Fang Yuan; Yuwen Su; Min Xu; Yufeng Pan; Yaoyu Chen; Yan Liu
Journal:  J Biol Chem       Date:  2018-04-08       Impact factor: 5.157

3.  The amyloid precursor protein (APP) intracellular domain regulates translation of p44, a short isoform of p53, through an IRES-dependent mechanism.

Authors:  Mi Li; Mariana Pehar; Yan Liu; Anita Bhattacharyya; Su-Chun Zhang; Kenneth J O'Riordan; Corinna Burger; Luciano D'Adamio; Luigi Puglielli
Journal:  Neurobiol Aging       Date:  2015-06-21       Impact factor: 4.673

Review 4.  Down syndrome and the complexity of genome dosage imbalance.

Authors:  Stylianos E Antonarakis
Journal:  Nat Rev Genet       Date:  2016-12-28       Impact factor: 53.242

5.  DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome.

Authors:  Xiao-Yan Tang; Lei Xu; Jingshen Wang; Yuan Hong; Yuanyuan Wang; Qian Zhu; Da Wang; Xin-Yue Zhang; Chun-Yue Liu; Kai-Heng Fang; Xiao Han; Shihua Wang; Xin Wang; Min Xu; Anita Bhattacharyya; Xing Guo; Mingyan Lin; Yan Liu
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 14.808

Review 6.  Neural Subtype Specification from Human Pluripotent Stem Cells.

Authors:  Yunlong Tao; Su-Chun Zhang
Journal:  Cell Stem Cell       Date:  2016-11-03       Impact factor: 24.633

7.  Challenges and Opportunities for Translation of Therapies to Improve Cognition in Down Syndrome.

Authors:  Sarah E Lee; Monica Duran-Martinez; Sabina Khantsis; Diana W Bianchi; Faycal Guedj
Journal:  Trends Mol Med       Date:  2019-11-07       Impact factor: 11.951

8.  The fetal brain transcriptome and neonatal behavioral phenotype in the Ts1Cje mouse model of Down syndrome.

Authors:  Faycal Guedj; Jeroen L A Pennings; Millie A Ferres; Leah C Graham; Heather C Wick; Klaus A Miczek; Donna K Slonim; Diana W Bianchi
Journal:  Am J Med Genet A       Date:  2015-05-14       Impact factor: 2.802

9.  Biallelic truncating mutations in FMN2, encoding the actin-regulatory protein Formin 2, cause nonsyndromic autosomal-recessive intellectual disability.

Authors:  Rosalind Law; Tracy Dixon-Salazar; Julie Jerber; Na Cai; Ansar A Abbasi; Maha S Zaki; Kirti Mittal; Stacey B Gabriel; Muhammad Arshad Rafiq; Valeed Khan; Maria Nguyen; Ghazanfar Ali; Brett Copeland; Eric Scott; Nasim Vasli; Anna Mikhailov; Muhammad Nasim Khan; Danielle M Andrade; Muhammad Ayaz; Muhammad Ansar; Muhammad Ayub; John B Vincent; Joseph G Gleeson
Journal:  Am J Hum Genet       Date:  2014-12-04       Impact factor: 11.025

Review 10.  Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.

Authors:  Alison E Mungenast; Sandra Siegert; Li-Huei Tsai
Journal:  Mol Cell Neurosci       Date:  2015-12-04       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.